K2 Biolabs LLC

The Gulf Coast Regional Blood Center began operations independent of the Medical Society on January 1, 1975, and began meeting the blood and blood component needs of patients being treated in 80 hospitals in a 16-county region. It has grown to serve more than 220 health care institutions in a 24-county Texas Gulf Coast region. Regional patient blood needs require that the Blood Center collect more than 273,000 units of blood and blood components from volunteer blood donors in 2006. 200,000 of these units are whole blood donations, which may be separated into their component parts to serve the specific transfusion needs of patients. An average of three components are available from each whole blood donation. Annual usage in this region exceeds over 720,000 units of blood and blood components. The Gulf Coast Regional Blood Center is located in Houston.

PhaRNA, LLC is a Houston-based company that specializes in the production and distribution of synthetic mRNA products. With the world's largest catalog of off-the-shelf mRNA products, they offer a wide range of synthetic mRNAs encoding common reporter proteins, which can be used for control markers in mRNA packaging and delivery optimization. Their mRNA products are synthesized with high capping efficiency, ensuring superior stability and translatability. In addition to reporter proteins, PhaRNA, LLC also provides mRNA mimetics for apoptotic processes and cytokine receptors. Their mRNA mimetics have been proven to have superior translational efficiency compared to recombinant DNA, making them a viable alternative for re-expressing proteins involved in apoptosis and cytokine-mediated immune response. With a focus on biomedical research, PhaRNA, LLC plays a crucial role in advancing scientific understanding and drug discovery efforts.Generated from the website

Laser Tissue Welding Inc. is a biotherapeutic medical device company based in Houston, Texas. Founded in 2004, the company specializes in the development of a revolutionary surgical sealant technology known as laser tissue welding. This innovative technology, which utilizes a diode laser and human albumin-based biodegradable materials, enables sutureless surgery and provides effective sealing of hemorrhage and fluid leaks, even in patients with coagulation failure. Laser Tissue Welding Inc. has gained recognition for its groundbreaking approach to surgical care. Their laser tissue welding device offers a point-and-shoot process that fuses tissue and stops bleeding immediately, potentially transforming the future of surgery and recovery. With a focus on vascular solid visceral organs such as the liver, kidney, and spleen, as well as hemostasis in coagulopathic patients, Laser Tissue Welding Inc. aims to provide accurate and instant sealing solutions without the need for traditional sutures or burning techniques.Generated from the website